ALX Oncology Holdings (ALXO) Stock Price, Quote, News & History

Comments

ALX Oncology Holdings Inc (ALXO) Stock Price, Quote, News & History

ALXONASDAQ

Trade with Public

$1.97

-0.01-0.51%

At close: Apr 2, 5:00 PM EST

$1.97

0.00020.01%

After Hours: 4:41 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$1.94

Close

$1.97

Volume / Avg.

415.13K / 673.34K

Day Range

$1.94 - $2.05

52 Wk Range

0.40 - 2.66

Market Cap

$259.29M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

1.09%

Days to Cover

2.38

Recent ALX Oncology Holdings Inc News

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month

Avi Kapoor

Crude Oil Moves Lower; Moderna Shares Plunge

Avi Kapoor

Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-84.14M

Investing Cash Flow (TTM)

82.59M

Financing Cash Flow (TTM)

362.00K

Free Cash Flow (TTM)

-84.35M

Capital Expenditure (TTM)

-212.00K

Net Change in Cash (TTM)

-1.19M

Analyst Trends and Forecast

1

Feb

2

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$224.89M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

10.00

Earnings Yield % (TTM)

-96.20%

Earnings Yield % (FWD)

-31.39%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.20

Company Debt

Total Debt

$9.75M

LT Debt

$4.53M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.36M

Total Cash

$16.37M

Debt to Equity

0.38

Issuance of Debt (TTM)

-$1.36M

Repayment of Debt (TTM)

-$1.36M

Key Statistics

Open

$1.94

Close

$1.97

Volume / Avg.

415.13K / 673.34K

Day Range

$1.94 - $2.05

52 Wk Range

0.40 - 2.66

Market Cap

$259.29M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

1.09%

Days to Cover

2.38

About

Sector

Health Care

Industry

Biotechnology

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy ALX Oncology Holdings (ALXO) stock?

A

You can purchase shares of ALX Oncology Holdings (NASDAQ:ALXO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ALX Oncology Holdings (ALXO) competitors?

A

Other companies in ALX Oncology Holdings’s space includes: Cabaletta Bio Inc (NASDAQ:CABA), Voyager Therapeutics Inc (NASDAQ:VYGR), AC Immune SA (NASDAQ:ACIU), Eledon Pharmaceuticals Inc (NASDAQ:ELDN) and Enlivex Ltd (NASDAQ:ENLV).

Q

What is the forecast, or price target, for ALX Oncology Holdings (ALXO) stock?

A

ALX Oncology Holdings has a consensus price target of $5.69.

Q

What is the current price for ALX Oncology Holdings (ALXO)?

A

The stock price for ALX Oncology Holdings (NASDAQ: ALXO) is $1.9702 last updated April 2, 2026 at 4:41 PM EDT.

Q

Does ALX Oncology Holdings (ALXO) pay a dividend?

A

There are no upcoming dividends for ALX Oncology Holdings.

Q

When is ALX Oncology Holdings (NASDAQ:ALXO) reporting earnings?

A

ALX Oncology Holdings does not have any upcoming earnings scheduled.

Q

Is ALX Oncology Holdings (ALXO) going to split?

A

There is no upcoming split for ALX Oncology Holdings.

Q

What sector and industry does ALX Oncology Holdings (ALXO) operate in?

A

ALX Oncology Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Voyager Therapeutics Inc

Eledon Pharmaceuticals Inc

Fennec Pharmaceuticals Inc

NASDAQ:FENC

$6.42

%

Silence Therapeutics PLC

NASDAQ:SLN

$5.47

-7.91%

Abeona Therapeutics Inc

NASDAQ:ABEO

$4.88

1.34%

Key Statistics

Open

$1.94

Close

$1.97

Volume / Avg.

415.13K / 673.34K

Day Range

$1.94 - $2.05

52 Wk Range

0.40 - 2.66

Market Cap

$259.29M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

1.09%

Days to Cover

2.38

Recent ALX Oncology Holdings Inc News

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month

Avi Kapoor

Crude Oil Moves Lower; Moderna Shares Plunge

Avi Kapoor

Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-84.14M

Investing Cash Flow (TTM)

82.59M

Financing Cash Flow (TTM)

362.00K

Free Cash Flow (TTM)

-84.35M

Capital Expenditure (TTM)

-212.00K

Net Change in Cash (TTM)

-1.19M

Analyst Trends and Forecast

1

Feb

2

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$224.89M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

10.00

Earnings Yield % (TTM)

-96.20%

Earnings Yield % (FWD)

-31.39%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.20

Company Debt

Total Debt

$9.75M

LT Debt

$4.53M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.36M

Total Cash

$16.37M

Debt to Equity

0.38

Issuance of Debt (TTM)

-$1.36M

Repayment of Debt (TTM)

-$1.36M

Key Statistics

Open

$1.94

Close

$1.97

Volume / Avg.

415.13K / 673.34K

Day Range

$1.94 - $2.05

52 Wk Range

0.40 - 2.66

Market Cap

$259.29M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

1.09%

Days to Cover

2.38

About

Sector

Health Care

Industry

Biotechnology

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry